Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$1.7M
4 rounds on record
Latest round
$1.7M
Venture round · Jul 2026 · 3 mo ago
Team
1-10
employees, estimated range
Grants
$734k
3 grants · CORDIS
The money's age
Fresh money
3 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 16 Raised a round Venture round $1.7M · SEC Form D Aug 15, 2021 Won a grant $229k · CORDIS May 1, 2021 Won a grant $250k · CORDIS Apr 1, 2021 Won a grant $255k · CORDIS 2018 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jul 2026 $1.7M — SEC Form D
Grant Aug 2021 $229k — CORDIS
Grant May 2021 $250k — CORDIS
Grant Apr 2021 $255k — CORDIS
Registers and programsofficial lists and records that name the company
Legal entity FluidForm Bio, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Adam FeinbergExecutive Officer, DirectorSEC Form D
Michael GraffeoExecutive Officer, DirectorSEC Form D
Erik WatersExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
NovadipVenture round $11.2M · this month
Novadip is committed to patients and addresses some of today’s biggest challenges in bone and tissue regenerative medicine.
CoreBoneVenture round $3.7M · 5 yr ago • 11-50 employees
CoreBone offers tissue regeneration solutions for Bone and Cartilage from cultivated corals.
Tavra BiosciencesVenture round $300k · 6 mo ago • Founded 2026 • 11-50 employees
Explore stem cells and regenerative medicine. Learn about mCELL™, published research, and resources for patients and physicians.
AdvancedsolutionsVenture round $1000k · 4 yr ago • Founded 2020 • 51-200 employees
Automate biological workflows with BioAssemblyBot robotics, AI-powered software and turnkey solutions for organoids, bioprinting and…
BrinterSeed $1.3M · 5 yr ago • 51-200 employees
Brinter is 3D bioprinting regenerative implants for the $1T tissue repair market. We develop bio-inductive, fully resorbable implants…
Discover Regenerative Medicine with D&P Bioinnovations. Transformative solutions for healing damaged tissues. Call us.

Overview

We build living human tissue using cells, proteins, and nothing else. Our technology leverages the intersection of personalized medicine, synthetic and computational biology, advanced materials, bioprinting, and AI to go from patient data to human tissue.

People

Adam Feinberg
Executive Officer, Director
Michael Graffeo
Executive Officer, Director
Erik Waters
Executive Officer
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Waltham United States
HQ
Get In Touch
1-10 est. staff
852 Winter Street, Waltham, MA 02451
company site

Financials

Total raised
$2.4M
Latest round
Venture - Series Unknown
Funding rounds
4
Funding rounds
Round Announced Amount
Venture - Series Unknown 2026 $1.7M Details
Grant 2021 $229k Details
Grant 2021 $250k Details
Grant 2021 $255k Details